A new era in drug regulation?
Hastings Center Report 35 (3):10-11 (2005)
| Abstract | This article has no associated abstract. (fix it) | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,701 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesRebecca Dresser (2002). Beyond Government Intervention: Drug Companies and Bioethics. American Journal of Bioethics 2 (3):42 – 43.
Hugh LaFollette (1994). Mandatory Drug Testing. In Steven Luper & C. Brown (eds.), Drugs, Morality, and the Law. Garland.
Hugh LaFollette (1994). Mandatory Drug Testing. In S. Luper & C. Brown (eds.), Drugs, Morality, and the Law. Garland.
Rinaldo B. Schinazi (2006). The Probability of Treatment Induced Drug Resistance. Acta Biotheoretica 54 (1).
Tal Scriven (1984). Utility, Autonomy and Drug Regulation. International Journal of Applied Philosophy 2 (2):27-42.
Ed Soule (2004). The Precautionary Principle and the Regulation of U.S. Food and Drug Safety. Journal of Medicine and Philosophy 29 (3):333 – 350.
Peter R. Mansfield (2005). Banning All Drug Promotion is the Best Option Pending Major Reforms. Journal of Bioethical Inquiry 2 (2).
Analytics
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2009-01-28Total downloads3 ( #202,008 of 549,115 )Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
